3rd Quarter - Report — CHAMBER HILL STRATEGIES for MARSHALL BIORESOURCES (2026)

Firm

CHAMBER HILL STRATEGIES

Client

MARSHALL BIORESOURCES

Income

$50,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 5048/HR 7248, the FDA Modernization Act; issues related to pre-clinical research; HR 10522, the Companion Animal Protection Against Cruel Testing Act; HR 10532, the Beagle Liberation Act

Lobbyist	Covered position, as disclosed
JENNIFER BELL	Health Policy Advisor, Sen. Finance Committee; Legislative Assistant, Rep. John Thune (R-SD)
JENNIFER HOLLAND	Scheduler, Rep. Mary Kaptur (OH-09); Operations Director, Rep. Donald Norcross (NJ-01); Scheduler, Rep. Debbie Dingell (MI-06)
KATHRYN MEADOWS	—
ABIGAIL ROSE	—
ZACHARY SCHULZ	Legislative Correspondent, Sen. Charles Grassley (R-IA)

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 10532 (119th), H.R. 7248 (119th), H.R. 10522 (119th), S. 5048 (119th)

Animals ANI

HR 10523, the Prohibiting Unethical Procedures on Pets in Science Act; HR 10627, the Animal Welfare Enforcement Improvement Act

Lobbyist	Covered position, as disclosed
JENNIFER BELL	Health Policy Advisor, Sen. Finance Committee; Legislative Assistant, Rep. John Thune (R-SD)
JENNIFER HOLLAND	Scheduler, Rep. Mary Kaptur (OH-09); Operations Director, Rep. Donald Norcross (NJ-01); Scheduler, Rep. Debbie Dingell (MI-06)
KATHRYN MEADOWS	—
ABIGAIL ROSE	—
ZACHARY SCHULZ	Legislative Correspondent, Sen. Charles Grassley (R-IA)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 10627 (119th), H.R. 10523 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.